^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

HS-10376

i
Other names: HS-10376, HS10376, HS 10376
Associations
Company:
Jiangsu Hansoh Pharma
Drug class:
HER2 exon 20 mutation inhibitor
Associations
over2years
Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer (clinicaltrials.gov)
P1/2, N=380, Recruiting, Jiangsu Hansoh Pharmaceutical Co., Ltd.
New P1/2 trial • HER2 exon 20
|
EGFR (Epidermal growth factor receptor) • HER-2 (Human epidermal growth factor receptor 2)
|
EGFR mutation • HER-2 mutation • EGFR exon 20 insertion • HER-2 exon 20 insertion • EGFR exon 20 mutation • HER-2 exon 23 mutation
|
HS-10376